HWM — Howmet Aerospace Inc.

Analysts are overwhelmingly bullish (21 buy, 3 hold, 1 sell; recent targets around $316-$340), and the August 6 Q2 print beat across the board: revenue +24% y/y, EPS $1.33 versus $1.22-$1.24 guidance, and FY26 EPS guidance raised to $5.23-$5.31. The stock has corrected from the highs, but the fundamental narrative is intact; the debate is multiple, not quality.

Growth is clearly accelerating: YoY revenue growth went from roughly 7%-11% in 2024 to 14%-15% in late 2025, then 19% in Q1 2026 and 24% in Q2 2026. Operating margins expanded from ~20%-23% in 2024 to ~25%-28% in 2025/2026; Q2 2026's reported 27.9% operating margin dipped from Q1's 32.6%, but the research brief attributes that to intentional capacity/labor launch costs, and adjusted EBITDA margin still rose 340 bps y/y to 32.1%. FCF is lumpy but positive; TTM FCF through Q2 2026 is about $1.57B. This is an inflection higher, not a one-off blip.

Expensive. As of 2026-08-27, TTM P/E is 57.3x versus the 5-year average of 42.2x, forward P/E is roughly 50x on FY26 EPS near $5.31, and P/S is 11.7x versus a 5-year average of 5.0x. PEG is about 1.6. Even with 20%+ organic growth and margin expansion, the multiple is pricing in near-perfect execution; this is the definition of rich vs. its own history.

The price has pulled back ~13.7% from $310 while estimates have been moving up, so the forward multiple has compressed from the high-50s to ~50x. That means a lot of the good news is already in the stock. If Q3 and the back half track the raised guidance, the stock can digest its gains; if any miss occurs, the high multiple makes the downside larger. The earnings trend is strong, but the playbook is momentum/expectations-driven, not deep value.

As of 2026-08-27, RSI was 40.77, price was 4.64% below the 20-day SMA and 3.69% below the 50-day SMA, but 9.7% above the 200-day SMA (roughly $244). That is a pullback within a longer uptrend: short-term momentum is soft, the stock is range-bound in the $260-$270 area, and the 200-day SMA is the next meaningful support. Entry timing favors patience/stability signals rather than chasing.

• Commercial aerospace aftermarket demand is strong; Engine Products grew 32% y/y in Q2 on flight hours and fleet utilization.
• Defense/aerospace content demand remains a tailwind, supporting structural and engine components.
• Industrial gas turbine and power-generation demand accelerated 38% y/y, with new Japan capacity adding a second growth pillar.
• Supply-chain and labor inflation: Howmet is hiring and adding capacity, creating temporary launch-cost margin pressure.
• High-beta, high-multiple stock is sensitive to interest rates and discount-rate changes.

• Q3 2026 earnings in early November: the first real test of whether revenue tracks the $2.57-$2.59B guide and raised FY26 targets.
• Jefferies Global Industrials Conference on September 9, 2026: CEO commentary on backlog, capacity ramp, and margins.
• Capital allocation: $800M of buybacks through July 2026 and a 17% dividend hike signal confidence.
• Further aftermarket/IGT capacity additions could drive another guidance raise.

• Valuation/multiple compression: 57x TTM and ~50x forward P/E leave little margin of safety.
• Execution risk on capacity expansion: labor/launch costs could pressure margins if volume growth slows.
• Aerospace OEM production or supply-chain disruptions (Boeing/Airbus) could hit engine and airframe demand.
• Insider selling of about $22.9M over trailing 12 months with zero insider buying is a caution flag.
• Cyclicality in aerospace aftermarket or a macro-driven traffic downturn would hit the high-margin aftermarket business.

Howmet is a high-quality compounder with accelerating revenue, expanding margins, clean cash conversion, and durable aerospace aftermarket/IGT tailwinds. At $267.65, however, the stock is not obviously cheap: roughly 50x forward earnings already capitalizes a lot of the strength. My lean is cautiously bullish—own the story, but wait for a better entry near the 200-day SMA (~$244) or for Q3 to confirm the raised guidance. This is analysis, not personalized investment advice.

Applied a justified forward P/E of 48x to FY26 consensus EPS of $5.314. The 48x multiple is a premium to the 5-year average P/E of 42.2x due to 20%+ organic growth, 32% adjusted EBITDA margins, ~18% ROIC, and clean cash conversion, but it is below the current ~57x TTM multiple and implies the stock is roughly fully valued at $267.65.